These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32936722)

  • 21. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
    Fukushima M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
    Wang HF; Lv JQ
    Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S-1 for the treatment of gastrointestinal cancer.
    Satoh T; Sakata Y
    Expert Opin Pharmacother; 2012 Sep; 13(13):1943-59. PubMed ID: 22860709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant S-1 chemotherapy after curative resection of gastric cancer in Chinese patients: assessment of treatment tolerability and associated risk factors.
    Yeo W; Lam KO; Law AL; Lee CC; Chiang CL; Au KH; Mo FK; So TH; Lam KC; Ng WT; Li L
    Hong Kong Med J; 2017 Feb; 23(1):54-62. PubMed ID: 27966431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working Group.
    Saek T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Aoyama H; Ota J; Noguchi S; Taguchi T
    Breast Cancer; 2004; 11(2):194-202. PubMed ID: 15550867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternate-day oral therapy with TS-1 for advanced gastric cancer.
    Arai W; Hosoya Y; Hyodo M; Yokoyama T; Hirashima Y; Yasuda Y; Nagai H; Shirasaka T
    Int J Clin Oncol; 2004 Jun; 9(3):143-8. PubMed ID: 15221596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer.
    Yamanaka T; Matsumoto S; Teramukai S; Ishiwata R; Nagai Y; Fukushima M
    Gastric Cancer; 2007; 10(2):129-34. PubMed ID: 17577624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1).
    Park YJ; Soh BW; Lee ES
    Eur J Dermatol; 2017 Apr; 27(2):209-210. PubMed ID: 28251899
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
    Hirata K; Horikoshi N; Aiba K; Okazaki M; Denno R; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Shirasaka T
    Clin Cancer Res; 1999 Aug; 5(8):2000-5. PubMed ID: 10473078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tegafur + gimeracil + oteracil. Just another fluorouracil precursor.
    Prescrire Int; 2013 May; 22(138):122. PubMed ID: 23819172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary toxicity by a cytotoxic agent, S-1.
    Tada Y; Takiguchi Y; Fujikawa A; Kitamura A; Kurosu K; Hiroshima K; Sakao S; Kasahara Y; Tanabe N; Tatsumi K; Kuriyama T
    Intern Med; 2007; 46(15):1243-6. PubMed ID: 17675777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoropyridmidine use and hypertriglyceridemia among Japanese patients: analysis of adverse event database.
    Mitsuboshi S; Niimura T; Yoshino M; Sakamoto Y; Zamami Y; Ishizawa K
    Int J Clin Pharm; 2022 Feb; 44(1):260-263. PubMed ID: 34482500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fluoropyrimidines cardiac toxicity: 5-fluorouracil, capecitabine, compound S-1 and trifluridine/tipiracil].
    Vaflard P; Ederhy S; Torregrosa C; André T; Cohen R; Lopez-Trabada D
    Bull Cancer; 2018; 105(7-8):707-719. PubMed ID: 29960638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The first case of phenytoin intoxication associated with the concomitant use of phenytoin and TS-1, a combination preparation of tegafur, gimeracil, and oteracil potassium.
    Tsuda A; Fujiyama J; Miki A; Hori S; Ohtani H; Sawada Y
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):427-32. PubMed ID: 18026730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG).
    Chollet P; Schöffski P; Weigang-Köhler K; Schellens JH; Cure H; Pavlidis N; Grünwald V; De Boer R; Wanders J; Fumoleau P;
    Eur J Cancer; 2003 Jun; 39(9):1264-70. PubMed ID: 12763215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group.
    Koizumi W; Kurihara M; Nakano S; Hasegawa K
    Oncology; 2000 Apr; 58(3):191-7. PubMed ID: 10765119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk associated with severe hematological toxicity in patients with advanced or recurrent colonic cancer receiving combination chemotherapy of S-1 and irinotecan hydrochloride].
    Sunaga T; Suzuki S; Harada N; Hayashi T; Suzuki M
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2137-41. PubMed ID: 21084813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conceptual changes in cancer chemotherapy: from an oral fluoropyrimidine prodrug, UFT, to a novel oral fluoropyrimidine prodrug, S-1, and low-dose FP therapy in Japan.
    Shirasaka T; Yamamitsu S; Tsuji A; Taguchi T
    Invest New Drugs; 2000 Nov; 18(4):315-29. PubMed ID: 11081568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetics of S-1 capsule in patients with advanced gastric cancer].
    Liu HY; Ding L; Yu Y; Chu Y; Zhu H
    Yao Xue Xue Bao; 2012 Oct; 47(10):1363-9. PubMed ID: 23289150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary toxicity by an oral anti-neoplatic agent, S-1.
    Ohara G; Satoh H; Hizawa N
    Intern Med; 2008; 47(3):187; author reply 189. PubMed ID: 18239333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.